Document is current
Any future updates will be listed below
-
Authors
Gurriaran-Rodriguez, Uxia
Kodippili, Kasun
Datzkiw, David
Javandoost, Ehsan
Xiao, Fan
Rejas, Maria Teresa
Rudnicki, Michael A.
-
Funding
Funding for this research was provided by:
Ontario Institute for Regenerative Medicine
Defeat Duchenne Canada
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR044031)
Canadian Institutes for Health Research (FDN-148387)
Stem Cell Network
- License Information
-
More Information
Article History
Received: 10 June 2024
Accepted: 4 December 2024
First Online: 19 December 2024
Declarations
:
: Housing, husbandry, and all experimental protocols for mice used in this study were performed in accordance with the guidelines established by the University of Ottawa Animal Care Committee, which is based on the guidelines of the Canadian Council on Animal Care. Committee’s reference number: 1. OHRIe-3868 - Experimental Protocol - Genetic Mouse Models for Investigating the Molecular Mechanisms of Muscle Regeneration [Expires June 30th, 2026]. 2. OHRIb-3826 - Breeding Protocol - Genetic Mouse Models for Investigating the Molecular Mechanisms of Muscle Regeneration [Expires March 31st, 2026].
: Not applicable.
: MAR is a co-inventor on patents pertaining to the use of Wnt7a to enhance muscle regeneration. The remaining authors declare no conflict of interest.
